Neuronetics (STIM) 10% Owner Jorey Chernett Buys 14,000 Shares

What Happened

• Jorey Chernett, listed as a 10% owner of Neuronetics, purchased 14,000 shares in an open-market transaction on 2026-08-14 at a weighted average price of $3.16 per share (total about $44,240).
• The filing also reports a disposal of 100 shares on 2026-08-13 classified as a derivative transaction (disposed at $3.21, proceeds $321). The purchase is a direct stock buy (often viewed as a stronger signal than routine sales); the disposal relates to a derivative/options activity per the footnotes.

Key Details

• Transaction dates and prices:
  • 2026-08-14: Purchase (P) — 14,000 shares @ $3.16 (weighted average); total ≈ $44,240. Footnote says prices ranged $3.13–$3.17 across multiple trades.
  • 2026-08-13: Sale/Disposition (S, derivative) — 100 shares @ $3.21; total $321. Footnote indicates this involved sale of call options and is matchable under Section 16(b).
• Shares owned following the transactions: Not specified in the provided filing.
• Footnotes of note:
  • F1: $3.16 is a weighted average; purchaser will provide breakdown of per-trade prices on request.
  • F2: The derivative sale is matchable under Section 16(b); the reporting person calculated a short-swing profit and intends to disgorge it to the issuer.
• Filing/Timing: Form 4 filed 2026-08-17 covering transactions on 8/13–8/14; this filing date appears to be within the normal two-business-day reporting window.

Context

• As a 10% owner (not necessarily an executive), Chernett is subject to Section 16 reporting rules; such holders can be institutional or large individual investors rather than company officers.
• The 14,000-share open-market purchase is a straightforward buy; the 100-share disposal reflects options/derivative activity and carries a note about potential short-swing disgorgement.
• No speculation on motives — purchases and small derivative disposals are factual events investors can track as part of insider activity.